SARS-CoV-2 Messenger RNA Vaccine Immunogenicity in Solid Organ Transplant Recipients With Prior COVID-19.
作者信息
Boyarsky Brian J, Barbur Iulia, Chiang Teresa Po-Yu, Ou Michael T, Greenberg Ross S, Teles Aura T, Krach Michelle R, López Julia I, Garonzik-Wang Jacqueline M, Avery Robin K, Massie Allan B, Segev Dorry L, Werbel William A
机构信息
Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
出版信息
Transplantation. 2021 Nov 1;105(11):e270-e271. doi: 10.1097/TP.0000000000003900.
Abstract
摘要
相似文献
1
SARS-CoV-2 Messenger RNA Vaccine Immunogenicity in Solid Organ Transplant Recipients With Prior COVID-19.
Transplantation. 2021 Nov 1;105(11):e270-e271. doi: 10.1097/TP.0000000000003900.
2
Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients.
JAMA. 2021 May 4;325(17):1784-1786. doi: 10.1001/jama.2021.4385.
3
A Fourth Dose of COVID-19 Vaccine Does Not Induce Neutralization of the Omicron Variant Among Solid Organ Transplant Recipients With Suboptimal Vaccine Response: Erratum.
Transplantation. 2024 May 1;108(5):e78. doi: 10.1097/TP.0000000000005004. Epub 2024 Apr 24.
4
Improved immunogenicity against SARS-CoV-2 in a solid-organ transplant recipient by switching vaccines.
Clin Microbiol Infect. 2021 Oct;27(10):1529-1530. doi: 10.1016/j.cmi.2021.06.022. Epub 2021 Jun 27.
5
Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients.
N Engl J Med. 2021 Sep 23;385(13):1244-1246. doi: 10.1056/NEJMc2111462. Epub 2021 Aug 11.
6
Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients.
N Engl J Med. 2021 Aug 12;385(7):661-662. doi: 10.1056/NEJMc2108861. Epub 2021 Jun 23.
7
Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients.
JAMA. 2021 Jun 1;325(21):2204-2206. doi: 10.1001/jama.2021.7489.
8
Higher Proinflammatory Cytokines Are Associated With Increased Antibody Titer After a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: Erratum.
Transplantation. 2024 May 1;108(5):e77. doi: 10.1097/TP.0000000000005003. Epub 2024 Apr 24.
9
Poor Humoral Response in Solid Organ Transplant Recipients Following Complete mRNA SARS-CoV-2 Vaccination.
Clin Chem. 2021 Dec 30;68(1):251-253. doi: 10.1093/clinchem/hvab149.
10
Serological Response to the BNT162b2 COVID-19 mRNA Vaccine in Adolescent and Young Adult Kidney Transplant Recipients.
Transplantation. 2021 Nov 1;105(11):e226-e233. doi: 10.1097/TP.0000000000003922.
引用本文的文献
1
SARS-CoV-2-specific immune responses converge in kidney disease patients and controls with hybrid immunity.
NPJ Vaccines. 2024 May 28;9(1):93. doi: 10.1038/s41541-024-00886-0.
2
Hybrid Immunity Provides the Best COVID-19 Humoral Response in Immunocompromised Patients with or without SARS-CoV-2 Infection History.
Vaccines (Basel). 2023 Aug 18;11(8):1380. doi: 10.3390/vaccines11081380.
3
Humoral vaccine response and breakthrough infections in kidney transplant recipients during the COVID-19 pandemic: a nationwide cohort study.
EClinicalMedicine. 2023 Jun;60:102035. doi: 10.1016/j.eclinm.2023.102035. Epub 2023 Jun 6.
4
Immunogenicity, Safety, and Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 Infections After Coronavirus Disease 2019 Vaccination in Organ Transplant Recipients: A Prospective Multicenter Canadian Study.
Open Forum Infect Dis. 2023 Apr 13;10(5):ofad200. doi: 10.1093/ofid/ofad200. eCollection 2023 May.
5
COVID-19 mortality may be reduced among fully vaccinated solid organ transplant recipients.
PLoS One. 2022 Dec 21;17(12):e0279222. doi: 10.1371/journal.pone.0279222. eCollection 2022.
6
COVID-19 Mortality in Vaccinated vs. Unvaccinated Liver & Kidney Transplant Recipients: A Single-Center United States Propensity Score Matching Study on Historical Data.
Vaccines (Basel). 2022 Nov 13;10(11):1921. doi: 10.3390/vaccines10111921.
7
Immunogenicity profiling and distinct immune response in liver transplant recipients vaccinated with SARS-CoV-2 inactivated vaccines.
Front Immunol. 2022 Sep 14;13:954177. doi: 10.3389/fimmu.2022.954177. eCollection 2022.
8
Seroconversion following the first, second, and third dose of SARS-CoV-2 vaccines in immunocompromised population: a systematic review and meta-analysis.
Virol J. 2022 Aug 8;19(1):132. doi: 10.1186/s12985-022-01858-3.
9
Immune Response after mRNA COVID-19 Vaccination in Lung Transplant Recipients: A 6-Month Follow-Up.
Vaccines (Basel). 2022 Jul 15;10(7):1130. doi: 10.3390/vaccines10071130.
10
Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper.
J Hepatol. 2022 Oct;77(4):1161-1197. doi: 10.1016/j.jhep.2022.07.008. Epub 2022 Jul 20.
Zotero 插件